FOLH1 and metastatic neoplasm: Hence, this study evaluates, to the best of our knowledge, the largest collective of PDTC and ATC patients with advanced metastatic disease investigated by 68Ga-PMSA-PET/CT, in terms of theranostics regarding an individual treatment concept in purpose of a 177Lu-PSMA therapy.